Fig. 7

(a) The uptake of [18F]FAPI and [18F]FDG for benign and malignant lymph nodes. (b) Receiver operating curve analysis of lymph nodes SUVmax on FAPI or FDG
(a) The uptake of [18F]FAPI and [18F]FDG for benign and malignant lymph nodes. (b) Receiver operating curve analysis of lymph nodes SUVmax on FAPI or FDG